Celestica, Inc. (CLS) Is a Trending Stock: Facts to Know Before Betting on It

06.10.25 15:00 Uhr

Werte in diesem Artikel

Celestica (CLS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Over the past month, shares of this electronics manufacturing services company have returned -3.7%, compared to the Zacks S&P 500 composite's +4.3% change. During this period, the Zacks Electronics - Manufacturing Services industry, which Celestica falls in, has gained 4.4%. The key question now is: What could be the stock's future direction?While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.For the current quarter, Celestica is expected to post earnings of $1.45 per share, indicating a change of +39.4% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.The consensus earnings estimate of $5.55 for the current fiscal year indicates a year-over-year change of +43%. This estimate has remained unchanged over the last 30 days.For the next fiscal year, the consensus earnings estimate of $6.78 indicates a change of +22.1% from what Celestica is expected to report a year ago. Over the past month, the estimate has changed +0.5%.With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Celestica.The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:12 Month EPSProjected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.In the case of Celestica, the consensus sales estimate of $3 billion for the current quarter points to a year-over-year change of +20%. The $11.63 billion and $13.67 billion estimates for the current and next fiscal years indicate changes of +20.6% and +17.5%, respectively.Last Reported Results and Surprise HistoryCelestica reported revenues of $2.89 billion in the last reported quarter, representing a year-over-year change of +21%. EPS of $1.39 for the same period compares with $0.91 a year ago.Compared to the Zacks Consensus Estimate of $2.67 billion, the reported revenues represent a surprise of +8.34%. The EPS surprise was +12.1%.Over the last four quarters, Celestica surpassed consensus EPS estimates three times. The company topped consensus revenue estimates three times over this period.ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.Celestica is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Celestica. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Celestica, Inc. (CLS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Quelle: Zacks

Nachrichten zu Celestica Inc. (Sub Voting)

Wer­bung

Analysen zu Celestica Inc. (Sub Voting)

DatumRatingAnalyst
17.08.2017Celestica BuyStandpoint Research
27.01.2017Celestica HoldStifel, Nicolaus & Co., Inc.
18.11.2016Celestica HoldStandpoint Research
15.01.2016Celestica Sector PerformRBC Capital Markets
30.10.2015Celestica Sector PerformRBC Capital Markets
DatumRatingAnalyst
17.08.2017Celestica BuyStandpoint Research
27.01.2017Celestica HoldStifel, Nicolaus & Co., Inc.
30.10.2014Celestica BuyStandpoint Research
25.10.2012Celestica buyParadigm Capital
17.10.2012Celestica sector outperformScotia Capital Markets
DatumRatingAnalyst
18.11.2016Celestica HoldStandpoint Research
15.01.2016Celestica Sector PerformRBC Capital Markets
30.10.2015Celestica Sector PerformRBC Capital Markets
21.10.2015Celestica Sector PerformRBC Capital Markets
07.12.2012Celestica sector performRBC Capital Markets
DatumRatingAnalyst
20.06.2011Celestica sellCitigroup Corp.
22.02.2007Celestica reduceUBS
22.07.2005Update Celestica Inc. (Sub Voting): UnderperformBear Stearns

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Celestica Inc. (Sub Voting) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen